Cheng Du Tian Tai Shan Zhi Yao Gu Fen You Xian Gong Si, established on 2000-09-29, Business scope includes licensed projects:pharmaceutical production;Drug retail;Drug import and export;road freight transport(Does not contain dangerous goods);Drug Wholesale;Pharmaceutical commissioned production.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Production of Chinese herbal extracts;Packaging special equipment manufacturing;Technology Import and Export;Chinese herbal medicine planting;real estate herbal medicine(Does not contain Chinese herbal medicine)buy and sell;Medical Research and Experimental Development;Specialty Chemicals Sales(Free of Hazardous Chemicals);Import and export;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;business management;Business Management Consulting;Commercial Complex Management Services.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Zhejiang Lihua New Material Technology Co., Ltd., established on 2017-07-25, Business scope includes general items:Heptafluoropropane,Perfluorohexanone,Research and development of ethyl difluoroacetate,manufacture,Sales;Hexafluoropropylene dimer,Hexafluoropropylene trimer production;Chemical raw materials and products(Free of hazardous chemicals and precursor chemicals)research and development,Sales(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Import and export;Technology Import and Export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

Ningbo Wanglong Technology Co., Ltd., established on 2009-10-21, Business scope includes licensed projects:Hazardous Chemical Production;Food additive production;Feed additive production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).General project:Food Additive Sales;Feed Additive Sales;water pollution control;Air Pollution Control;Solid Waste Treatment(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Shanghai Livzon Pharmaceutical Co., Ltd., established on 1995-04-11, The business scope includes freeze-dried powder injection(hormones),powder injection(hormones),small volume injection,tablet,hard capsule,API,Production of pharmaceutical excipients(The operating permit),engaged in biotechnology(human stem cells,Except for the development and application of genetic diagnosis and treatment technology),Medical Technology,Technology development in the field of chemical product technology,technical consulting,Technical Services,technology transfer,Engaged in the import and export of goods and technology,Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,civilian explosives,precursor chemicals)promotion of. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Shijiazhuang Synthetic Chemical Co., Ltd., established on 1998-06-26, Business scope includes synthetic chemicals and intermediates,potassium sulfate,potassium chloride,potassium carbonate,ammonium sulfate,ammonium chloride,Ammonium Bicarbonate Production,Sales(Free of Hazardous and Precursor Chemicals);sulfuric acid production,Sales(branch only).(All of the above business scope laws,Matters prohibited or restricted by regulations and decisions of the State Council shall not be operated;Matters requiring approval from other departments,Can operate after approval)**

Rhone-Poulenc Rorer Ltd. engages in the research, production and distribution of pharmaceutical products. The company is headquartered in Guildford, the United Kingdom.

Hitachi Zosen Corp. engages in the design and construction of environmental systems, industrial plants, industrial machinery, process and infrastructure-related equipment, disaster prevention systems, and precision machinery. It operates through the following segments: Environment, Machinery and Infrastructure, and Other. The Environment segment manages recycling facilities, water and sludge treatment facilities, power generation equipment, biomass utilization systems, and seawater desalination plants. The Machinery and Infrastructure segment offers marine motors and machineries, denitrification catalysts, pressure vessels, plastic machineries, food machineries, pharmaceutical machineries, electronics and control systems, and disaster prevention systems. The Other segment includes transportation, warehousing, and cargo handling businesses. The company was founded by Edward H. Hunter on April 1, 1881 and is headquartered in Osaka, Japan.

Hangzhou Xinhai Pharmaceutical Technology Co., Ltd., established on 2019-07-15, Business scope includes technology development,technical consulting,Technical Services,Achievement transfer:medical technology,Pharmaceutical Intermediates,medical instruments,Chemical reagents and products,Biological product,Biotechnology(The above except pharmaceuticals,Medical service,Hazardous chemicals and precursor chemicals),Healthy food;Sales:Pharmaceutical Intermediates,Chemical products and raw materials,chemical reagent(Removal of hazardous chemicals and precursor chemicals),medical instruments(Limited to one category);Import and export of goods and technology(law,Except for items prohibited by administrative regulations,Projects that are restricted by laws and administrative regulations can only be operated after obtaining a license).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shandong New Pharmaceutical Co., Ltd., established on 2020-03-24, Business scope includes production:Chemical raw materials and their preparations,food additives,Feed additives,Pharmaceutical Intermediates(None of the above contain hazardous chemicals);Sales:Pharmaceutical Intermediates(Free of Hazardous Chemicals);Research and development of biotechnology;Goods and technology import and export business permitted by the state.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Purelite (China) Co., Ltd., established on 1996-10-16, The business scope includes production and sales of ion exchange resins and water purification products,By-products such as foreign products ion exchange resin and foreign products white ball,By-product dilute sulfuric acid,By-product dilute methanol,By-product Calcium Sulfate;Engage in non-quota license management,Acquisition and export business of non-franchised commodities.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Part of Suzhou Electrical Apparatus Science Academy Co., Ltd., Suzhou Guohuan Environment Detection Co., Ltd. is a Chinese company located in Suzhou. The firm provides laboratory testing services. Suzhou Electrical Apparatus Science Academy Co., Ltd. acquired Suzhou Guohuan Environment Detection Co., Ltd. from Suzhou National Envmt. New & Hi-Tech Ind. Park Dev. Co. Ltd. on January 19, 2013 for $3.33 million.

Affymax is a biopharmaceutical company committed to developing novel drugs to improve the treatment of serious and often life-threatening conditions. The company's first product candidate, peginesatide (formerly known as Hematideâ„¢), has been investigated in Phase 3 trials for the potential treatment of anemia associated with chronic kidney disease (CKD). A New Drug Application (NDA) for peginesatide for the treatment of anemia associated with CKD in adult patients on dialysis is currently being reviewed by the U.S. Food and Drug Administration (FDA).